Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
150 GBX | +2.39% | +9.89% | -17.81% |
May. 20 | Arecor Therapeutics' Investigational Insulin Shows Fast Absorption in Early-stage Study | MT |
May. 20 | Arecor Therapeutics hails positive profile for insulin AT278 | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.81% | 57M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+48.60% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- AREC Stock
- News Arecor Therapeutics plc
- Arecor Therapeutics to Receive Milestone Payment from Maiden Commercial Sale of Arestat Technology Product